> top > docs > PMC:7597510 > annotations

PMC:7597510 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid_Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 1898-1901 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T2 1898-1901 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T3 1908-1912 https://glytoucan.org/Structures/Glycans/G17077FL denotes GQ1b
T4 1908-1912 https://glytoucan.org/Structures/Glycans/G18625KA denotes GQ1b
T5 1922-1926 https://glytoucan.org/Structures/Glycans/G37184KW denotes GD1b
T6 1922-1926 https://glytoucan.org/Structures/Glycans/G97612UN denotes GD1b
T7 4462-4469 https://glytoucan.org/Structures/Glycans/G15021LG denotes glucose
T8 4806-4809 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T9 4806-4809 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T10 4811-4814 https://glytoucan.org/Structures/Glycans/G61168WC denotes GM2
T11 4811-4814 https://glytoucan.org/Structures/Glycans/G79389NT denotes GM2
T12 4816-4820 https://glytoucan.org/Structures/Glycans/G46677TE denotes GD1a
T13 4816-4820 https://glytoucan.org/Structures/Glycans/G69277LC denotes GD1a
T14 4822-4826 https://glytoucan.org/Structures/Glycans/G37184KW denotes GD1b
T15 4822-4826 https://glytoucan.org/Structures/Glycans/G97612UN denotes GD1b
T16 4828-4831 https://glytoucan.org/Structures/Glycans/G81928IQ denotes GD3
T17 4828-4831 https://glytoucan.org/Structures/Glycans/G98544DH denotes GD3
T18 4833-4844 https://glytoucan.org/Structures/Glycans/G92175CL denotes GalNAc-GD1a
T19 4846-4850 https://glytoucan.org/Structures/Glycans/G68110IF denotes GT1a
T20 4846-4850 https://glytoucan.org/Structures/Glycans/G93468NI denotes GT1a
T21 4852-4856 https://glytoucan.org/Structures/Glycans/G05952XV denotes GT1b
T22 4852-4856 https://glytoucan.org/Structures/Glycans/G40183QN denotes GT1b
T23 4858-4862 https://glytoucan.org/Structures/Glycans/G17077FL denotes GQ1b
T24 4858-4862 https://glytoucan.org/Structures/Glycans/G18625KA denotes GQ1b
T25 4872-4882 https://glytoucan.org/Structures/Glycans/G00407UJ denotes asialo-GM1
T26 4872-4882 https://glytoucan.org/Structures/Glycans/G21856LC denotes asialo-GM1
T27 9377-9380 https://glytoucan.org/Structures/Glycans/G46613JI denotes GM1
T28 9377-9380 https://glytoucan.org/Structures/Glycans/G48558GR denotes GM1
T29 9387-9391 https://glytoucan.org/Structures/Glycans/G17077FL denotes GQ1b
T30 9387-9391 https://glytoucan.org/Structures/Glycans/G18625KA denotes GQ1b
T31 9401-9405 https://glytoucan.org/Structures/Glycans/G37184KW denotes GD1b
T32 9401-9405 https://glytoucan.org/Structures/Glycans/G97612UN denotes GD1b

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 557-567 Body_part denotes lower limb http://purl.org/sig/ont/fma/fma7184
T2 610-618 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T3 738-746 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T4 1261-1272 Body_part denotes glycolipids http://purl.org/sig/ont/fma/fma82780
T5 1281-1292 Body_part denotes ganglioside http://purl.org/sig/ont/fma/fma82816
T6 1802-1810 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T7 2937-2948 Body_part denotes extremities http://purl.org/sig/ont/fma/fma7182
T8 3161-3166 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T9 3615-3632 Body_part denotes lower extremities http://purl.org/sig/ont/fma/fma7184
T10 3663-3680 Body_part denotes upper extremities http://purl.org/sig/ont/fma/fma7183
T11 3741-3752 Body_part denotes extremities http://purl.org/sig/ont/fma/fma7182
T12 3835-3857 Body_part denotes central nervous system http://purl.org/sig/ont/fma/fma55675
T13 3859-3865 Body_part denotes Tendon http://purl.org/sig/ont/fma/fma9721
T14 3882-3899 Body_part denotes upper extremities http://purl.org/sig/ont/fma/fma7183
T15 3946-3963 Body_part denotes lower extremities http://purl.org/sig/ont/fma/fma7184
T16 4010-4016 Body_part denotes muscle http://purl.org/sig/ont/fma/fma32558
T17 4066-4073 Body_part denotes muscles http://purl.org/sig/ont/fma/fma32558
T18 4081-4098 Body_part denotes lower extremities http://purl.org/sig/ont/fma/fma7184
T19 4140-4147 Body_part denotes muscles http://purl.org/sig/ont/fma/fma32558
T20 4155-4172 Body_part denotes upper extremities http://purl.org/sig/ont/fma/fma7183
T21 4350-4361 Body_part denotes extremities http://purl.org/sig/ont/fma/fma7182
T22 4428-4433 Body_part denotes Blood http://purl.org/sig/ont/fma/fma9670
T23 4456-4461 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T24 4462-4469 Body_part denotes glucose http://purl.org/sig/ont/fma/fma82743
T25 4507-4515 Body_part denotes collagen http://purl.org/sig/ont/fma/fma63891
T26 4525-4532 Body_part denotes thyroid http://purl.org/sig/ont/fma/fma9603
T27 4567-4586 Body_part denotes Cerebrospinal fluid http://purl.org/sig/ont/fma/fma20935
T28 4588-4591 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T29 4670-4677 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T30 4689-4693 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T31 4762-4773 Body_part denotes ganglioside http://purl.org/sig/ont/fma/fma82816
T32 4885-4896 Body_part denotes Ganglioside http://purl.org/sig/ont/fma/fma82816
T33 4998-5001 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T34 5202-5208 Body_part denotes muscle http://purl.org/sig/ont/fma/fma32558
T35 5270-5283 Body_part denotes tibial nerves http://purl.org/sig/ont/fma/fma19035
T36 5455-5460 Body_part denotes Nerve http://purl.org/sig/ont/fma/fma65132
T37 5484-5489 Body_part denotes nerve http://purl.org/sig/ont/fma/fma65132
T38 5507-5512 Body_part denotes Nerve http://purl.org/sig/ont/fma/fma65132
T39 5776-5781 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T40 5881-5886 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T41 5887-5892 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T42 5924-5929 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T43 6030-6035 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T44 6036-6041 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T45 6075-6080 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T46 6156-6161 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T47 6162-6167 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T48 6311-6315 Body_part denotes Knee http://purl.org/sig/ont/fma/fma24974
T49 6363-6368 Body_part denotes Ankle http://purl.org/sig/ont/fma/fma9665
T50 6449-6455 Body_part denotes fibula http://purl.org/sig/ont/fma/fma24479
T51 6456-6461 Body_part denotes ankle http://purl.org/sig/ont/fma/fma9665
T52 6491-6496 Body_part denotes nerve http://purl.org/sig/ont/fma/fma65132
T53 6514-6519 Body_part denotes Nerve http://purl.org/sig/ont/fma/fma65132
T54 6711-6716 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T55 6787-6792 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T56 6793-6798 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T57 6854-6859 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T58 6934-6939 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T59 6940-6945 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T60 6999-7004 Body_part denotes Wrist http://purl.org/sig/ont/fma/fma24922
T61 7078-7083 Body_part denotes Elbow http://purl.org/sig/ont/fma/fma24901
T62 7084-7089 Body_part denotes wrist http://purl.org/sig/ont/fma/fma24922
T63 7190-7195 Body_part denotes Ankle http://purl.org/sig/ont/fma/fma9665
T64 7273-7295 Body_part denotes abductor digiti minimi http://purl.org/sig/ont/fma/fma37451
T65 7302-7326 Body_part denotes abductor pollicis brevis http://purl.org/sig/ont/fma/fma37373
T66 7380-7405 Body_part denotes extensor digitorum brevis http://purl.org/sig/ont/fma/fma51140
T67 7412-7428 Body_part denotes extensor indicis http://purl.org/sig/ont/fma/fma38524
T68 7444-7466 Body_part denotes flexor hallucis brevis http://purl.org/sig/ont/fma/fma37449
T69 8073-8087 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T70 8282-8297 Body_part denotes Achilles tendon http://purl.org/sig/ont/fma/fma51061
T71 8971-8982 Body_part denotes ganglioside http://purl.org/sig/ont/fma/fma82816
T72 9171-9182 Body_part denotes ganglioside http://purl.org/sig/ont/fma/fma82816
T73 10142-10153 Body_part denotes endothelium http://purl.org/sig/ont/fma/fma63916
T74 10300-10310 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T75 10337-10345 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T76 10736-10751 Body_part denotes lower extremity http://purl.org/sig/ont/fma/fma7184
T77 10837-10848 Body_part denotes lower limbs http://purl.org/sig/ont/fma/fma7184
T78 10871-10886 Body_part denotes lower extremity http://purl.org/sig/ont/fma/fma7184
T79 11200-11203 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T80 12873-12881 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 563-567 Body_part denotes limb http://purl.obolibrary.org/obo/UBERON_0002101
T2 3161-3166 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T3 3835-3857 Body_part denotes central nervous system http://purl.obolibrary.org/obo/UBERON_0001017
T4 3843-3857 Body_part denotes nervous system http://purl.obolibrary.org/obo/UBERON_0001016
T5 3859-3865 Body_part denotes Tendon http://purl.obolibrary.org/obo/UBERON_0000043
T6 3994-3999 Body_part denotes Scale http://purl.obolibrary.org/obo/UBERON_0002542
T7 4428-4433 Body_part denotes Blood http://purl.obolibrary.org/obo/UBERON_0000178
T8 4456-4461 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T9 4525-4532 Body_part denotes thyroid http://purl.obolibrary.org/obo/UBERON_0002046
T10 4567-4586 Body_part denotes Cerebrospinal fluid http://purl.obolibrary.org/obo/UBERON_0001359
T11 5270-5283 Body_part denotes tibial nerves http://purl.obolibrary.org/obo/UBERON_0001323
T12 5455-5460 Body_part denotes Nerve http://purl.obolibrary.org/obo/UBERON_0001021
T13 5484-5489 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T14 5507-5512 Body_part denotes Nerve http://purl.obolibrary.org/obo/UBERON_0001021
T15 5881-5886 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T16 6030-6035 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T17 6156-6161 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T18 6311-6315 Body_part denotes Knee http://purl.obolibrary.org/obo/UBERON_0001465
T19 6449-6455 Body_part denotes fibula http://purl.obolibrary.org/obo/UBERON_0001446
T20 6483-6496 Body_part denotes Sensory nerve http://purl.obolibrary.org/obo/UBERON_0001027
T21 6491-6496 Body_part denotes nerve http://purl.obolibrary.org/obo/UBERON_0001021
T22 6514-6519 Body_part denotes Nerve http://purl.obolibrary.org/obo/UBERON_0001021
T23 6787-6792 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T24 6934-6939 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T25 7078-7083 Body_part denotes Elbow http://purl.obolibrary.org/obo/UBERON_0001461
T26 8291-8297 Body_part denotes tendon http://purl.obolibrary.org/obo/UBERON_0000043
T27 10142-10153 Body_part denotes endothelium http://purl.obolibrary.org/obo/UBERON_0001986

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 0-23 Disease denotes Guillain-Barré syndrome http://purl.obolibrary.org/obo/MONDO_0016218
T2 30-38 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 86-109 Disease denotes Guillain-Barré syndrome http://purl.obolibrary.org/obo/MONDO_0016218
T4 111-114 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T5 132-140 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T6 143-152 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T7 221-229 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T8 232-241 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T9 374-377 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T10 520-528 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T11 531-540 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T12 549-552 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T13 868-876 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T14 879-888 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T15 971-974 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T16 991-999 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T17 1002-1011 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T18 1025-1048 Disease denotes Guillain-Barré syndrome http://purl.obolibrary.org/obo/MONDO_0016218
T19 1050-1053 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T20 1075-1097 Disease denotes polyradiculoneuropathy http://purl.obolibrary.org/obo/MONDO_0006915
T21 1143-1152 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T22 1195-1198 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T23 1223-1232 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T24 1448-1451 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T25 1468-1476 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T26 1479-1488 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T27 1618-1626 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T28 1629-1638 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T29 1647-1650 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T30 1974-1982 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T31 1985-1994 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T32 2006-2009 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T33 2022-2069 Disease denotes acute inflammatory demyelinating polyneuropathy http://purl.obolibrary.org/obo/MONDO_0016218
T34 2041-2069 Disease denotes demyelinating polyneuropathy http://purl.obolibrary.org/obo/MONDO_0003334
T35 2055-2069 Disease denotes polyneuropathy http://purl.obolibrary.org/obo/MONDO_0001824
T36 2076-2117 Disease denotes Acute motor and sensory axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0020348
T37 2100-2117 Disease denotes axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0004183
T38 2107-2117 Disease denotes neuropathy http://purl.obolibrary.org/obo/MONDO_0005244
T39 2122-2151 Disease denotes acute motor axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0020349
T40 2134-2151 Disease denotes axonal neuropathy http://purl.obolibrary.org/obo/MONDO_0004183
T41 2141-2151 Disease denotes neuropathy http://purl.obolibrary.org/obo/MONDO_0005244
T42 2257-2260 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T43 2277-2285 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T44 2288-2297 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T45 2404-2412 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T46 2415-2424 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T47 2433-2436 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T48 2667-2675 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T49 2678-2687 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T50 2696-2699 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T51 2775-2785 Disease denotes thrombosis http://purl.obolibrary.org/obo/MONDO_0000831
T52 2844-2850 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T53 3109-3117 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T54 3138-3147 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T55 3365-3371 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T56 3471-3477 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T57 4217-4220 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T58 4404-4410 Disease denotes ataxia http://purl.obolibrary.org/obo/MONDO_0000437
T59 4507-4523 Disease denotes collagen disease http://purl.obolibrary.org/obo/MONDO_0005554
T60 4525-4540 Disease denotes thyroid disease http://purl.obolibrary.org/obo/MONDO_0003240
T61 4867-4870 Disease denotes GA1 http://purl.obolibrary.org/obo/MONDO_0009281
T62 5021-5029 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T63 5384-5390 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T64 5930-5933 Disease denotes ADM http://purl.obolibrary.org/obo/MONDO_0043317
T65 7268-7271 Disease denotes ADM http://purl.obolibrary.org/obo/MONDO_0043317
T66 7582-7585 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T67 7882-7892 Disease denotes vasculitis http://purl.obolibrary.org/obo/MONDO_0018882
T68 8037-8040 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T69 8547-8550 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T70 8567-8575 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T71 8578-8587 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T72 8627-8630 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T73 8786-8789 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T74 8831-8839 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T75 8842-8851 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T76 8866-8869 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T77 9065-9087 Disease denotes Miller-Fisher syndrome http://purl.obolibrary.org/obo/MONDO_0005851
T78 9115-9118 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T79 9548-9551 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T80 9606-9610 Disease denotes Zika http://purl.obolibrary.org/obo/MONDO_0018661
T81 9829-9832 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T82 9849-9857 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T83 9987-9995 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T84 10000-10003 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T85 10029-10032 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T86 10110-10118 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T87 10300-10330 Disease denotes macrophage activation syndrome http://purl.obolibrary.org/obo/MONDO_0015545
T88 10372-10375 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T89 10393-10401 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T90 10404-10413 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T91 10561-10569 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T92 10675-10678 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T93 10695-10703 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T94 10706-10715 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T95 11078-11081 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T96 11178-11181 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T97 11301-11304 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T98 11321-11329 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T99 11332-11341 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T100 11535-11538 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T101 11546-11554 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T102 11557-11566 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T103 11609-11617 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T104 11803-11826 Disease denotes Guillain-Barré syndrome http://purl.obolibrary.org/obo/MONDO_0016218
T105 12147-12170 Disease denotes Guillain-Barré syndrome http://purl.obolibrary.org/obo/MONDO_0016218
T106 12172-12175 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T107 12193-12201 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T108 12204-12213 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T109 12296-12299 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T110 12321-12342 Disease denotes peripheral neuropathy http://purl.obolibrary.org/obo/MONDO_0003620|http://purl.obolibrary.org/obo/MONDO_0005244
T112 12369-12377 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T113 12530-12533 Disease denotes GBS http://purl.obolibrary.org/obo/MONDO_0016218
T114 12550-12558 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T115 12561-12570 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 163-167 http://purl.obolibrary.org/obo/CLO_0001599 denotes A 54
T2 246-252 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T3 563-567 http://www.ebi.ac.uk/efo/EFO_0000876 denotes limb
T4 619-624 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T5 1594-1595 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 1864-1869 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T7 1938-1942 http://purl.obolibrary.org/obo/CLO_0001406 denotes 5–14
T8 2235-2236 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 2321-2327 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T10 2806-2810 http://purl.obolibrary.org/obo/CLO_0001599 denotes A 54
T11 2831-2832 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T12 2937-2948 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T13 3078-3082 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T14 3161-3166 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T15 3621-3632 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T16 3669-3680 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T17 3741-3752 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T18 3835-3857 http://purl.obolibrary.org/obo/UBERON_0001017 denotes central nervous system
T19 3835-3857 http://www.ebi.ac.uk/efo/EFO_0000302 denotes central nervous system
T20 3835-3857 http://www.ebi.ac.uk/efo/EFO_0000908 denotes central nervous system
T21 3859-3865 http://www.ebi.ac.uk/cellline#tendon denotes Tendon
T22 3859-3865 http://www.ebi.ac.uk/efo/EFO_0000952 denotes Tendon
T23 3888-3899 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T24 3952-3963 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T25 4010-4016 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscle
T26 4010-4016 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscle
T27 4010-4016 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscle
T28 4010-4016 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscle
T29 4066-4080 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscles of the
T30 4066-4080 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscles of the
T31 4066-4080 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscles of the
T32 4066-4073 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscles
T33 4087-4098 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T34 4140-4154 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscles of the
T35 4140-4154 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscles of the
T36 4140-4154 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscles of the
T37 4140-4147 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscles
T38 4161-4172 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T39 4350-4361 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremities
T40 4428-4433 http://purl.obolibrary.org/obo/UBERON_0000178 denotes Blood
T41 4428-4433 http://www.ebi.ac.uk/efo/EFO_0000296 denotes Blood
T42 4434-4439 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T43 4456-4461 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T44 4456-4461 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T45 4507-4515 http://purl.obolibrary.org/obo/CHEBI_3815 denotes collagen
T46 4689-4693 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T47 4706-4711 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T48 4811-4814 http://purl.obolibrary.org/obo/CLO_0003535 denotes GM2
T49 4978-4979 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T50 5010-5016 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T51 5202-5208 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscle
T52 5202-5208 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscle
T53 5202-5208 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscle
T54 5202-5208 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscle
T55 5277-5283 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T56 5371-5372 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T57 5428-5429 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T58 5455-5460 http://purl.obolibrary.org/obo/UBERON_0001021 denotes Nerve
T59 5484-5489 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
T60 5507-5512 http://purl.obolibrary.org/obo/UBERON_0001021 denotes Nerve
T61 5530-5532 http://purl.obolibrary.org/obo/CLO_0007874 denotes ms
T62 5545-5548 http://purl.obolibrary.org/obo/CLO_0007874 denotes m/s
T63 5591-5593 http://purl.obolibrary.org/obo/CLO_0007874 denotes ms
T64 5871-5873 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T65 6491-6496 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
T66 6514-6519 http://purl.obolibrary.org/obo/UBERON_0001021 denotes Nerve
T67 6537-6539 http://purl.obolibrary.org/obo/CLO_0007874 denotes ms
T68 6552-6555 http://purl.obolibrary.org/obo/CLO_0007874 denotes m/s
T69 6745-6747 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T70 6892-6894 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T71 8257-8259 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T72 8282-8297 http://sig.uw.edu/fma#Calcaneal_tendon denotes Achilles tendon
T73 8425-8431 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerves
T74 8955-8961 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T75 9194-9200 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T76 9319-9325 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T77 9356-9362 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T78 9437-9443 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T79 9499-9504 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tests
T80 9573-9574 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T81 9611-9616 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T82 9731-9733 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T83 9764-9768 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T84 10091-10094 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T85 10142-10153 http://purl.obolibrary.org/obo/UBERON_0001986 denotes endothelium
T86 10203-10204 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T87 10311-10321 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T88 10361-10362 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T89 10414-10416 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T90 10742-10751 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremity
T91 10843-10848 http://www.ebi.ac.uk/efo/EFO_0000876 denotes limbs
T92 10877-10886 http://www.ebi.ac.uk/efo/EFO_0000876 denotes extremity
T93 11204-11208 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T94 11350-11354 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T95 11703-11705 http://purl.obolibrary.org/obo/CLO_0050475 denotes My
T96 11756-11759 http://purl.obolibrary.org/obo/CLO_0001302 denotes 3–4
T97 11767-11769 http://purl.obolibrary.org/obo/CLO_0050475 denotes My
T98 11782-11784 http://purl.obolibrary.org/obo/CLO_0007653 denotes me
T99 11953-11955 http://purl.obolibrary.org/obo/CLO_0050475 denotes my
T100 12218-12222 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T101 12594-12596 http://purl.obolibrary.org/obo/CLO_0008246 denotes OK
T102 13005-13006 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T103 13211-13215 http://purl.obolibrary.org/obo/CLO_0008416 denotes peer
T104 13211-13215 http://purl.obolibrary.org/obo/CLO_0050081 denotes peer
T105 13253-13257 http://purl.obolibrary.org/obo/CLO_0008416 denotes peer
T106 13253-13257 http://purl.obolibrary.org/obo/CLO_0050081 denotes peer

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 1261-1272 Chemical denotes glycolipids http://purl.obolibrary.org/obo/CHEBI_33563
T2 1281-1292 Chemical denotes ganglioside http://purl.obolibrary.org/obo/CHEBI_28892
T3 1898-1901 Chemical denotes GM1 http://purl.obolibrary.org/obo/CHEBI_18216|http://purl.obolibrary.org/obo/CHEBI_61048|http://purl.obolibrary.org/obo/CHEBI_73110
T6 1908-1912 Chemical denotes GQ1b http://purl.obolibrary.org/obo/CHEBI_27515
T7 1922-1926 Chemical denotes GD1b http://purl.obolibrary.org/obo/CHEBI_28175
T8 2726-2728 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T9 2729-2734 Chemical denotes gamma http://purl.obolibrary.org/obo/CHEBI_30212
T10 3168-3174 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T11 3260-3270 Chemical denotes budesonide http://purl.obolibrary.org/obo/CHEBI_3207
T12 3272-3291 Chemical denotes formoterol fumarate http://purl.obolibrary.org/obo/CHEBI_31633
T13 3272-3282 Chemical denotes formoterol http://purl.obolibrary.org/obo/CHEBI_5147
T14 3283-3291 Chemical denotes fumarate http://purl.obolibrary.org/obo/CHEBI_29806
T15 3292-3299 Chemical denotes hydrate http://purl.obolibrary.org/obo/CHEBI_35505
T16 3304-3322 Chemical denotes montelukast sodium http://purl.obolibrary.org/obo/CHEBI_6993
T17 3304-3315 Chemical denotes montelukast http://purl.obolibrary.org/obo/CHEBI_50730
T18 3316-3322 Chemical denotes sodium http://purl.obolibrary.org/obo/CHEBI_26708
T19 3394-3407 Chemical denotes betamethasone http://purl.obolibrary.org/obo/CHEBI_3077
T20 4462-4469 Chemical denotes glucose http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167
T22 4544-4551 Chemical denotes vitamin http://purl.obolibrary.org/obo/CHEBI_33229
T23 4670-4677 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T24 4762-4773 Chemical denotes ganglioside http://purl.obolibrary.org/obo/CHEBI_28892
T25 4774-4782 Chemical denotes antigens http://purl.obolibrary.org/obo/CHEBI_59132
T26 4806-4809 Chemical denotes GM1 http://purl.obolibrary.org/obo/CHEBI_18216|http://purl.obolibrary.org/obo/CHEBI_61048|http://purl.obolibrary.org/obo/CHEBI_73110
T29 4811-4814 Chemical denotes GM2 http://purl.obolibrary.org/obo/CHEBI_141420|http://purl.obolibrary.org/obo/CHEBI_51013|http://purl.obolibrary.org/obo/CHEBI_60327|http://purl.obolibrary.org/obo/CHEBI_89635
T33 4816-4820 Chemical denotes GD1a http://purl.obolibrary.org/obo/CHEBI_18163|http://purl.obolibrary.org/obo/CHEBI_82607
T35 4822-4826 Chemical denotes GD1b http://purl.obolibrary.org/obo/CHEBI_28175
T36 4828-4831 Chemical denotes GD3 http://purl.obolibrary.org/obo/CHEBI_28424|http://purl.obolibrary.org/obo/CHEBI_89636
T38 4833-4844 Chemical denotes GalNAc-GD1a http://purl.obolibrary.org/obo/CHEBI_59228
T39 4833-4839 Chemical denotes GalNAc http://purl.obolibrary.org/obo/CHEBI_28037|http://purl.obolibrary.org/obo/CHEBI_28800
T41 4840-4844 Chemical denotes GD1a http://purl.obolibrary.org/obo/CHEBI_18163|http://purl.obolibrary.org/obo/CHEBI_82607
T43 4846-4850 Chemical denotes GT1a http://purl.obolibrary.org/obo/CHEBI_27691
T44 4852-4856 Chemical denotes GT1b http://purl.obolibrary.org/obo/CHEBI_28058
T45 4858-4862 Chemical denotes GQ1b http://purl.obolibrary.org/obo/CHEBI_27515
T46 4867-4870 Chemical denotes GA1 http://purl.obolibrary.org/obo/CHEBI_27717|http://purl.obolibrary.org/obo/CHEBI_27938
T48 4879-4882 Chemical denotes GM1 http://purl.obolibrary.org/obo/CHEBI_18216|http://purl.obolibrary.org/obo/CHEBI_61048|http://purl.obolibrary.org/obo/CHEBI_73110
T51 4885-4896 Chemical denotes Ganglioside http://purl.obolibrary.org/obo/CHEBI_28892
T52 4938-4946 Chemical denotes antigens http://purl.obolibrary.org/obo/CHEBI_59132
T53 5535-5543 Chemical denotes Velocity http://purl.obolibrary.org/obo/CHEBI_145500
T54 6369-6372 Chemical denotes EDB http://purl.obolibrary.org/obo/CHEBI_28534
T55 6542-6550 Chemical denotes Velocity http://purl.obolibrary.org/obo/CHEBI_145500
T56 7375-7378 Chemical denotes EDB http://purl.obolibrary.org/obo/CHEBI_28534
T57 7961-7967 Chemical denotes metals http://purl.obolibrary.org/obo/CHEBI_33521
T58 7978-7984 Chemical denotes toxins http://purl.obolibrary.org/obo/CHEBI_27026
T59 8070-8072 Chemical denotes IV http://purl.obolibrary.org/obo/CHEBI_74327
T60 8971-8982 Chemical denotes ganglioside http://purl.obolibrary.org/obo/CHEBI_28892
T61 9171-9182 Chemical denotes ganglioside http://purl.obolibrary.org/obo/CHEBI_28892
T62 9377-9380 Chemical denotes GM1 http://purl.obolibrary.org/obo/CHEBI_18216|http://purl.obolibrary.org/obo/CHEBI_61048|http://purl.obolibrary.org/obo/CHEBI_73110
T65 9387-9391 Chemical denotes GQ1b http://purl.obolibrary.org/obo/CHEBI_27515
T66 9401-9405 Chemical denotes GD1b http://purl.obolibrary.org/obo/CHEBI_28175
T67 11845-11850 Chemical denotes gamma http://purl.obolibrary.org/obo/CHEBI_30212
T68 12587-12589 Chemical denotes TH http://purl.obolibrary.org/obo/CHEBI_73663
T69 12782-12784 Chemical denotes TH http://purl.obolibrary.org/obo/CHEBI_73663
T70 12850-12852 Chemical denotes YH http://purl.obolibrary.org/obo/CHEBI_73695
T71 12857-12859 Chemical denotes KK http://purl.obolibrary.org/obo/CHEBI_74564

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1 30-38 Disease denotes COVID-19 MESH:C000657245
15 177-182 Species denotes woman Tax:9606
16 347-354 Species denotes patient Tax:9606
17 506-514 Species denotes patients Tax:9606
18 854-862 Species denotes patients Tax:9606
19 132-152 Disease denotes SARS-CoV-2 infection MESH:C000657245
20 193-214 Disease denotes neurological symptoms MESH:D009422
21 221-241 Disease denotes SARS-CoV-2 infection MESH:C000657245
22 520-540 Disease denotes SARS-CoV-2-infection MESH:C000657245
23 758-781 Disease denotes microvascular disorders MESH:D017566
24 789-816 Disease denotes vascular endothelial damage MESH:D057772
25 829-850 Disease denotes neurological symptoms MESH:D009422
26 868-888 Disease denotes SARS-CoV-2 infection MESH:C000657245
27 991-1011 Disease denotes SARS-CoV-2 infection MESH:C000657245
45 2309-2316 Species denotes patient Tax:9606
46 2755-2763 Species denotes patients Tax:9606
47 1281-1292 Chemical denotes ganglioside MESH:D005732
48 1898-1901 Chemical denotes GM1 MESH:D005677
49 1075-1097 Disease denotes polyradiculoneuropathy MESH:D011129
50 1143-1152 Disease denotes infection MESH:D007239
51 1223-1232 Disease denotes infection MESH:D007239
52 1468-1488 Disease denotes SARS-CoV-2 infection MESH:C000657245
53 1618-1638 Disease denotes SARS-CoV-2-infection MESH:C000657245
54 1974-1994 Disease denotes SARS-CoV-2-infection MESH:C000657245
55 2041-2069 Disease denotes demyelinating polyneuropathy MESH:D003711
56 2092-2117 Disease denotes sensory axonal neuropathy MESH:C536450
57 2122-2151 Disease denotes acute motor axonal neuropathy MESH:D000208
58 2277-2297 Disease denotes SARS-CoV-2 infection MESH:C000657245
59 2404-2424 Disease denotes SARS-CoV-2-infection MESH:C000657245
60 2667-2687 Disease denotes SARS-CoV-2-infection MESH:C000657245
61 2775-2785 Disease denotes thrombosis MESH:D013927
89 4112-4128 Gene denotes proximal and 4/4
90 4038-4054 Gene denotes proximal and 5/5
91 4393-4396 Gene denotes she Gene:126669
92 4174-4177 Gene denotes she Gene:126669
93 3704-3707 Gene denotes she Gene:126669
94 3575-3578 Gene denotes she Gene:126669
95 3130-3133 Gene denotes she Gene:126669
96 3007-3010 Gene denotes she Gene:126669
97 2820-2825 Species denotes woman Tax:9606
98 3109-3119 Species denotes SARS-CoV-2 Tax:2697049
99 3168-3174 Chemical denotes oxygen MESH:D010100
100 3260-3270 Chemical denotes budesonide MESH:D019819
101 3272-3299 Chemical denotes formoterol fumarate hydrate MESH:D000068759
102 3304-3322 Chemical denotes montelukast sodium MESH:C093875
103 3394-3407 Chemical denotes betamethasone MESH:D001623
104 2844-2850 Disease denotes asthma MESH:D001249
105 2908-2916 Disease denotes numbness MESH:D006987
106 2921-2929 Disease denotes weakness MESH:D018908
107 2984-3005 Disease denotes neurological symptoms MESH:D009422
108 3021-3026 Disease denotes cough MESH:D003371
109 3031-3036 Disease denotes fever MESH:D005334
110 3138-3147 Disease denotes pneumonia MESH:D011014
111 3365-3371 Disease denotes asthma MESH:D001249
112 3471-3477 Disease denotes asthma MESH:D001249
113 3599-3607 Disease denotes numbness MESH:D006987
114 3725-3733 Disease denotes weakness MESH:D018908
115 4404-4410 Disease denotes ataxia MESH:D001259
127 4828-4831 Gene denotes GD3 Gene:117189
128 5021-5031 Species denotes SARS-CoV-2 Tax:2697049
129 5055-5062 Species denotes patient Tax:9606
130 5359-5366 Species denotes patient Tax:9606
131 4462-4469 Chemical denotes glucose MESH:D005947
132 4762-4773 Chemical denotes ganglioside MESH:D005732
133 4885-4896 Chemical denotes Ganglioside MESH:D005732
134 4507-4523 Disease denotes collagen disease MESH:D003095
135 4525-4540 Disease denotes thyroid disease MESH:D013959
136 4544-4565 Disease denotes vitamin abnormalities MESH:D014802
137 5384-5390 Disease denotes asthma MESH:D001249
139 7099-7111 Species denotes L  Malleolus Tax:273487
142 7297-7300 Gene denotes APB Gene:6051
143 7444-7459 Disease denotes flexor hallucis MESH:D052582
148 7724-7727 Gene denotes She Gene:126669
149 7907-7910 Gene denotes she Gene:126669
150 7882-7892 Disease denotes vasculitis MESH:D014657
151 7918-7928 Disease denotes malignancy MESH:D009369
154 8042-8045 Gene denotes she Gene:126669
155 8010-8017 Species denotes patient Tax:9606
160 8469-8472 Gene denotes she Gene:126669
161 8226-8229 Gene denotes she Gene:126669
162 8446-8454 Disease denotes weakness MESH:D018908
163 8497-8505 Disease denotes numbness MESH:D006987
167 8567-8587 Disease denotes SARS-CoV-2 infection MESH:C000657245
168 8794-8820 Disease denotes neurological complications MESH:D002493
169 8831-8851 Disease denotes SARS-CoV-2 infection MESH:C000657245
191 8911-8919 Species denotes patients Tax:9606
192 9038-9046 Species denotes patients Tax:9606
193 9327-9335 Species denotes patients Tax:9606
194 9606-9616 Species denotes Zika virus Tax:64320
195 9629-9637 Species denotes patients Tax:9606
196 9849-9859 Species denotes SARS-CoV-2 Tax:2697049
197 9973-9981 Species denotes patients Tax:9606
198 10110-10120 Species denotes SARS-CoV-2 Tax:2697049
199 10379-10387 Species denotes patients Tax:9606
200 10547-10555 Species denotes patients Tax:9606
201 8971-8982 Chemical denotes ganglioside MESH:D005732
202 9171-9182 Chemical denotes ganglioside MESH:D005732
203 9377-9380 Chemical denotes GM1 MESH:D005677
204 9949-9969 Disease denotes respiratory symptoms MESH:D012818
205 9987-9995 Disease denotes COVID-19 MESH:C000657245
206 10168-10178 Disease denotes axonopathy MESH:D016472
207 10205-10227 Disease denotes microvascular disorder MESH:D017566
208 10393-10413 Disease denotes SARS-CoV-2 infection MESH:C000657245
209 10459-10480 Disease denotes neurological symptoms MESH:D009422
210 10523-10543 Disease denotes respiratory symptoms MESH:D012818
211 10561-10569 Disease denotes COVID-19 MESH:C000657245
223 10827-10834 Species denotes patient Tax:9606
224 10982-10990 Species denotes patients Tax:9606
225 11125-11132 Species denotes patient Tax:9606
226 10695-10715 Disease denotes SARS-CoV-2 infection MESH:C000657245
227 10742-10760 Disease denotes extremity weakness MESH:D018908
228 10765-10777 Disease denotes paraesthesia MESH:D010292
229 10792-10813 Disease denotes neurological symptoms MESH:D009422
230 10850-10866 Disease denotes Axonal disorders MESH:D012183
231 10877-10904 Disease denotes extremity dominant symptoms MESH:D051271
232 10957-10969 Disease denotes neuropathies MESH:D009422
233 10996-11011 Disease denotes microangiopathy MESH:D000783
237 11287-11295 Species denotes patients Tax:9606
238 11321-11341 Disease denotes SARS-CoV-2 infection MESH:C000657245
239 11546-11566 Disease denotes SARS-CoV-2 infection MESH:C000657245
241 11568-11575 Species denotes Patient Tax:9606
248 11596-11603 Disease denotes anxious MESH:D001007
249 11609-11617 Disease denotes COVID-19 MESH:C000657245
250 11640-11661 Disease denotes neurological symptoms MESH:D009422
251 11670-11691 Disease denotes numbness and weakness MESH:D006987
252 12018-12026 Disease denotes weakness MESH:D018908
253 12053-12061 Disease denotes numbness MESH:D006987
256 12133-12141 Species denotes Patients Tax:9606
257 12193-12213 Disease denotes SARS-CoV-2 infection MESH:C000657245
262 12346-12354 Species denotes patients Tax:9606
263 12369-12379 Species denotes SARS-CoV-2 Tax:2697049
264 12321-12342 Disease denotes peripheral neuropathy MESH:D010523
265 12355-12363 Disease denotes infected MESH:D007239
267 12550-12570 Disease denotes SARS-CoV-2 infection MESH:C000657245
269 12841-12848 Species denotes patient Tax:9606
271 13153-13160 Species denotes Patient Tax:9606

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 738-753 Phenotype denotes cytokine storms http://purl.obolibrary.org/obo/HP_0033041
T2 2041-2054 Phenotype denotes demyelinating http://purl.obolibrary.org/obo/HP_0011096
T3 2055-2069 Phenotype denotes polyneuropathy http://purl.obolibrary.org/obo/HP_0001271
T4 2092-2117 Phenotype denotes sensory axonal neuropathy http://purl.obolibrary.org/obo/HP_0003390
T5 2128-2151 Phenotype denotes motor axonal neuropathy http://purl.obolibrary.org/obo/HP_0007002
T6 2844-2850 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T7 3021-3026 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T8 3031-3036 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T9 3138-3147 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T10 3365-3371 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T11 3471-3477 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T12 3814-3857 Phenotype denotes abnormalities in the central nervous system http://purl.obolibrary.org/obo/HP_0002011
T13 4404-4410 Phenotype denotes ataxia http://purl.obolibrary.org/obo/HP_0001251
T14 4525-4540 Phenotype denotes thyroid disease http://purl.obolibrary.org/obo/HP_0000820
T15 5384-5390 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T16 7818-7845 Phenotype denotes elevated sedimentation rate http://purl.obolibrary.org/obo/HP_0003565
T17 7882-7892 Phenotype denotes vasculitis http://purl.obolibrary.org/obo/HP_0002633
T18 8282-8297 Phenotype denotes Achilles tendon http://purl.obolibrary.org/obo/HP_0025273
T19 10337-10351 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T20 10736-10760 Phenotype denotes lower extremity weakness http://purl.obolibrary.org/obo/HP_0007340
T21 12321-12342 Phenotype denotes peripheral neuropathy http://purl.obolibrary.org/obo/HP_0009830
T22 12407-12428 Phenotype denotes autoimmune conditions http://purl.obolibrary.org/obo/HP_0002960

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 3060-3073 http://purl.obolibrary.org/obo/GO_0003968 denotes transcriptase
T2 3060-3073 http://purl.obolibrary.org/obo/GO_0003899 denotes transcriptase
T3 5209-5225 http://purl.obolibrary.org/obo/GO_0001508 denotes action potential
T4 8298-8304 http://purl.obolibrary.org/obo/GO_0060004 denotes reflex
T5 10300-10321 http://purl.obolibrary.org/obo/GO_0042116 denotes macrophage activation
T6 12117-12125 http://purl.obolibrary.org/obo/GO_0007612 denotes Learning

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-47 Sentence denotes Guillain-Barré syndrome after COVID-19 in Japan
T2 49-57 Sentence denotes Abstract
T3 58-162 Sentence denotes We report the first case of Guillain-Barré syndrome (GBS) associated with SARS-CoV-2 infection in Japan.
T4 163-242 Sentence denotes A 54-year-old woman developed neurological symptoms after SARS-CoV-2 infection.
T5 243-342 Sentence denotes We tested for various antiganglioside antibodies, that had not been investigated in previous cases.
T6 343-479 Sentence denotes The patient was diagnosed with GBS based on neurological and electrophysiological findings; no antiganglioside antibodies were detected.
T7 480-639 Sentence denotes In previous reports, most patients with SARS-CoV-2-infection-related GBS had lower limb predominant symptoms, and antiganglioside antibody tests were negative.
T8 640-889 Sentence denotes Our findings support the notion that non-immune abnormalities such as hyperinflammation following cytokine storms and microvascular disorders due to vascular endothelial damage may lead to neurological symptoms in patients with SARS-CoV-2 infection.
T9 890-1012 Sentence denotes Our case further highlights the need for careful diagnosis in suspected cases of GBS associated with SARS-CoV-2 infection.
T10 1014-1024 Sentence denotes BACKGROUND
T11 1025-1169 Sentence denotes Guillain-Barré syndrome (GBS) is an acute type of polyradiculoneuropathy, that occurs following immune events such as infection and vaccination.
T12 1170-1339 Sentence denotes Approximately 40%–70% of GBS cases develop following infection, and autoantibodies against glycolipids (mainly ganglioside antibodies) are detected in over 50% of cases.
T13 1340-1502 Sentence denotes The cause is generally accepted to be an abnormality in the immune process.1 2 Recently, several reports of GBS associated with SARS-CoV-2 infection have emerged.
T14 1503-2075 Sentence denotes However, as far as we have investigated, there are still no reports in Japan.3 However, in a review of 37 cases of SARS-CoV-2-infection-related GBS, less than half of the studies investigated antiganglioside antibodies.4 Furthermore, few reports have provided details related to the antiganglioside antibody investigated, and clear descriptions of the relevant tests are available only for anti-GM1, anti-GQ1b and anti-GD1b antibodies.5–14 Most reported cases (64.8%) of SARS-CoV-2-infection-associated GBS were of the acute inflammatory demyelinating polyneuropathy type.
T15 2076-2367 Sentence denotes Acute motor and sensory axonal neuropathy and acute motor axonal neuropathy types were observed in 13.5% and 2.7% of cases.4 In the present report, we discuss a case of axonal-type GBS associated with SARS-CoV-2 infection, where the patient was tested for various antiganglioside antibodies.
T16 2368-2568 Sentence denotes Furthermore, we review the cases of SARS-CoV-2-infection-related GBS reported to date, in order to provide insight into the clinical characteristics and pathological mechanisms underlying the disease.
T17 2569-2786 Sentence denotes Our report also highlights the need for clinicians to remain cautious when attempting to diagnose SARS-CoV-2-infection-related GBS, and when using high-dose IV gamma globulin therapy in patients at risk of thrombosis.
T18 2788-2805 Sentence denotes Case presentation
T19 2806-2949 Sentence denotes A 54-year-old woman with a history of asthma was admitted to our hospital in May 2020 with reports of numbness and weakness in her extremities.
T20 2950-3120 Sentence denotes Twenty days prior to the onset of neurological symptoms, she developed cough and fever; oropharyngeal reverse transcriptase PCR test results were positive for SARS-CoV-2.
T21 3121-3190 Sentence denotes Although she had pneumonia on CT of the chest, oxygen was not needed.
T22 3191-3372 Sentence denotes Therefore, we did not administer additional treatment, and continued budesonide, formoterol fumarate hydrate and montelukast sodium, that were originally being used to treat asthma.
T23 3373-3478 Sentence denotes In addition, we used betamethasone only for the first 2 days to avoid the risk of exacerbation of asthma.
T24 3479-3551 Sentence denotes Following approximately 2 weeks of treatment, PCR results were negative.
T25 3552-3681 Sentence denotes However, at that time, she began to experience numbness in the lower extremities, that gradually spread to the upper extremities.
T26 3682-3753 Sentence denotes Within the next week, she began to develop weakness in the extremities.
T27 3754-3858 Sentence denotes Neurological examination revealed no findings suggestive of abnormalities in the central nervous system.
T28 3859-3964 Sentence denotes Tendon reflexes in the upper extremities were normal, although they were absent in the lower extremities.
T29 3965-4195 Sentence denotes The Medical Research Council Scale grade for muscle strength was 4/4 for proximal and 5/5 for distal muscles of the lower extremities, and 4/4 for proximal and 4/4 for distal muscles of the upper extremities; she was able to walk.
T30 4196-4293 Sentence denotes Her modified Erasmus GBS Outcome Score (mEGOS) was 3/9, while her Hughes’ functional grade was 2.
T31 4294-4411 Sentence denotes Superficial sensation was mildly impaired in the distal extremities, deep sensation was normal and she had no ataxia.
T32 4413-4427 Sentence denotes Investigations
T33 4428-4566 Sentence denotes Blood tests revealed normal blood glucose levels and no findings suggestive of collagen disease, thyroid disease or vitamin abnormalities.
T34 4567-4701 Sentence denotes Cerebrospinal fluid (CSF) assessment at admission at approximately 3 weeks after onset revealed normal protein levels and cell counts.
T35 4702-4757 Sentence denotes All tests for antiganglioside antibodies were negative.
T36 4758-4884 Sentence denotes The ganglioside antigens used in the ELISA were GM1, GM2, GD1a, GD1b, GD3, GalNAc-GD1a, GT1a, GT1b, GQ1b and GA1 (asialo-GM1).
T37 4885-5036 Sentence denotes Ganglioside complexes containing two of the above 10 antigens were also used as described in a previous study.15 CSF was not tested for SARS-CoV-2 PCR.
T38 5037-5115 Sentence denotes On admission, the patient’s first electrophysiological examination was normal.
T39 5116-5348 Sentence denotes However, the second examination performed 1 week later revealed decreases in compound muscle action potential (CMAP) amplitudes in the median, radial and tibial nerves compared with those obtained in the first examination (table 1).
T40 5349-5445 Sentence denotes Since the patient had a history of asthma, we did not perform lumbar MRI using a contrast agent.
T41 5446-5477 Sentence denotes Table 1 Nerve conduction study
T42 5478-5506 Sentence denotes Motor nerve conduction study
T43 5507-5594 Sentence denotes Nerve Distal latency (ms) Velocity (m/s) Amplitude (mV) F-wave minimal latency (ms)
T44 5595-5765 Sentence denotes At admission 1 week later 1 month later At admission 1 week later 1 month later At admission 1 week later 1 month later At admission 1 week later 1 month later
T45 5766-5774 Sentence denotes Median L
T46 5775-5879 Sentence denotes  Wrist–APB 3.4 (N<4.0) 3.7 3.4 57.7(N>50) 55.6 57.7 10.8 (N>7) 7.8 10.9 24.0 (N<29) 22 22.8
T47 5880-5914 Sentence denotes  Elbow–wrist 9.6 7.5 10.2
T48 5915-5922 Sentence denotes Ulnar L
T49 5923-6028 Sentence denotes  Wrist–ADM 2.6 (N<3.4) 2.6 2.8 58.8 (N>50) 56.4 60.8 10.0 (N>7) 11.1 8.2 21.1 (N<30) 24 23.2
T50 6029-6064 Sentence denotes  Elbow–wrist 9.4 10.7 7.7
T51 6065-6073 Sentence denotes Radial L
T52 6074-6154 Sentence denotes  Wrist–EIP 2.6 (N<2.9) 2.4 2.4 56.9 (N>50) 55.6 61.4 7.2 (N>7) 5.0 5.7
T53 6155-6189 Sentence denotes  Elbow–wrist 6.1 4.5 5.2
T54 6190-6198 Sentence denotes Tibial L
T55 6199-6309 Sentence denotes  Malleolus–FHB 3.6 (N<6.0) 3.8 3.2 50.8 (N>40) 46.5 46.9 22.6 (N>5) 16.3 20.3 42.8 (N<50) 46 44.1
T56 6310-6350 Sentence denotes  Knee–malleolus 18.6 13.9 15.7
T57 6351-6361 Sentence denotes Peroneal L
T58 6362-6441 Sentence denotes  Ankle–EDB 3.9 (N<5.5) 4.4 3.7 46.4 (N>40) 45.4 47.2 6.6 (N>5) 6.4 8.2
T59 6442-6482 Sentence denotes  Below fibula–ankle 6.2 5.7 7.0
T60 6483-6513 Sentence denotes Sensory nerve conduction study
T61 6514-6572 Sentence denotes Nerve Distal latency (ms) Velocity (m/s) Amplitude (mV)
T62 6573-6700 Sentence denotes At admission 1 week later 1 month later At admission 1 week later 1 month later At admission 1 week later 1 month later
T63 6701-6709 Sentence denotes Median L
T64 6710-6785 Sentence denotes  Wrist 3.1 (N<4.0) 3 3 48.4 (N>45) 49.0 48.7 24.1 (N>10) 22.9 19.1
T65 6786-6844 Sentence denotes  Elbow–wrist 60.1 (N>50) 56.1 61.1 12.1 12.5 10.8
T66 6845-6852 Sentence denotes Ulnar L
T67 6853-6932 Sentence denotes  Wrist 2.1 (N<3.4) 2.2 2.2 53.7 (N>45) 56.3 53.6 16.9 (N>10) 17.2 18.9
T68 6933-6988 Sentence denotes  Elbow–wrist 66.3 (N>50) 61.0 64.6 5.9 6.3 6.1
T69 6989-6997 Sentence denotes Radial L
T70 6998-7076 Sentence denotes  Wrist 2.5 (N<2.9) 1.8 2.1 58.5 (N>50) 56.8 59.1 19.1 (N>7) 21.3 18.2
T71 7077-7089 Sentence denotes  Elbow–wrist
T72 7090-7100 Sentence denotes Peroneal L
T73 7101-7180 Sentence denotes  Malleolus 2.7 (N<6.0) 2.7 3.4 51.9 (N>40) 52.2 47.3 3.2 (N>5) 7.3 3.2
T74 7181-7188 Sentence denotes Sural L
T75 7189-7267 Sentence denotes  Ankle 2.1 (N<5.5) 2.8 2.2 46.7 (N>40) 49.6 47.7 10.4 (N>5) 11.9 13.7
T76 7268-7487 Sentence denotes ADM, abductor digiti minimi; APB, abductor pollicis brevis; Bold, at least 20% lower than the first value; EDB, extensor digitorum brevis; EIP, extensor indicis proprius; FHB, flexor hallucis brevis; L, left; N, normal.
T77 7489-7511 Sentence denotes Differential diagnosis
T78 7512-7723 Sentence denotes This case fulfilled two of the required features for the diagnosis of GBS based on the criteria described by Asbury and Cornblath.16 In addition, several other clinical features strongly supported the diagnosis.
T79 7724-7893 Sentence denotes She had no systemic symptoms, multiorgan involvement or elevation of serological markers (eg, elevated sedimentation rate or rheumatoid factor) suggestive of vasculitis.
T80 7894-7985 Sentence denotes Furthermore, she had no malignancy or history of exposure to heavy metals and other toxins.
T81 7987-7996 Sentence denotes Treatment
T82 7997-8134 Sentence denotes Although the patient was diagnosed with GBS, she was followed up without IV immunoglobulin therapy due to her mEGOS and functional grade.
T83 8136-8157 Sentence denotes Outcome and follow-up
T84 8158-8323 Sentence denotes Approximately 2 weeks later, her symptoms had begun to improve, and she was discharged home on day 18; normalisation of the Achilles tendon reflex was also observed.
T85 8324-8432 Sentence denotes An electrophysiological examination performed 1 month later revealed improved CMAP amplitude in most nerves.
T86 8433-8506 Sentence denotes Although her weakness had improved, she continued to experience numbness.
T87 8508-8518 Sentence denotes Discussion
T88 8519-8897 Sentence denotes Although the possibility of GBS associated with SARS-CoV-2 infection remains to be clarified, the number of GBS cases reported between March 2020 and April 2020 is greater than five times that reported in the last 3 years.17 Given that reports have begun to describe GBS and neurological complications following SARS-CoV-2 infection, the onset of GBS requires special attention.
T89 8898-9020 Sentence denotes Among the 37 patients described by Caress et al, 17 were tested for anti-ganglioside antibodies, 15 of whom were negative.
T90 9021-9119 Sentence denotes In addition, two patients were positive for Miller-Fisher syndrome, and all were negative for GBS.
T91 9120-9233 Sentence denotes However, specific description of types of the anti-ganglioside antibodies tested were not provided in many cases.
T92 9234-9547 Sentence denotes Although some reports specifically described the types of antiganglioside antibodies tested, patients appear to have been tested only for anti-GM1, anti-GQ1b and anti-GD1b antibodies.9 10 14 Although we tested for various additional antiganglioside antibodies, all tests were negative in the present case as well.
T93 9548-9860 Sentence denotes GBS was also reported in a case–control study of the 2016 Zika virus, where most patients were negative for antiganglioside antibodies, suggesting the existence of unknown antibodies.18 Therefore, it is important to test for as many kinds of antibodies as possible when suspecting GBS associated with SARS-CoV-2.
T94 9861-10072 Sentence denotes However, some authors have reported nearly simultaneous development of neurological and respiratory symptoms in patients with COVID-19 and GBS.19 20 Thus, the cause of GBS may not be immune related in all cases.
T95 10073-10228 Sentence denotes Previous research has suggested that SARS-CoV-2 damages the vascular endothelium.21 Therefore, axonopathy may have been caused by a microvascular disorder.
T96 10229-10643 Sentence denotes In addition, McGonagle et al proposed that hyperinflammation following macrophage activation syndrome (ie, ‘cytokine storm’) may be a cause of GBS in patients with SARS-CoV-2 infection.22 Together, these findings suggest that, if neurological symptoms develop early following the appearance of respiratory symptoms in patients with COVID-19, both autoimmune and other factors should be considered in the diagnosis.
T97 10644-10849 Sentence denotes Whittaker et al noted that the GBS associated with SARS-CoV-2 infection manifests mainly as lower extremity weakness and paraesthesia.23 Similarly, neurological symptoms began in our patient’s lower limbs.
T98 10850-11012 Sentence denotes Axonal disorders and lower extremity dominant symptoms may be similar in character to the length-dependent neuropathies observed in patients with microangiopathy.
T99 11013-11182 Sentence denotes The present case satisfied the essential diagnostic criteria for GBS described by Asbury and Cornblath, and the patient’s clinical course supported the diagnosis of GBS.
T100 11183-11235 Sentence denotes Nonetheless, the CSF test yielded atypical findings.
T101 11236-11395 Sentence denotes In conclusion, our report supports the notion that patients with GBS associated with SARS-CoV-2 infection tend to test negative for antiganglioside antibodies.
T102 11396-11567 Sentence denotes In addition to careful diagnosis, further reports are required to elucidate the characteristics and the mechanisms underlying the onset of GBS due to SARS-CoV-2 infection.
T103 11568-11589 Sentence denotes Patient’s perspective
T104 11590-11702 Sentence denotes I was anxious when COVID-19 symptoms improved and neurological symptoms such as numbness and weakness developed.
T105 11703-11766 Sentence denotes My symptoms gradually progressed and peaked in about 3–4 weeks.
T106 11767-11827 Sentence denotes My doctor told me that I might have Guillain-Barré syndrome.
T107 11828-11965 Sentence denotes I was told about gamma globulin treatment, but I declined that option due to the risk of side effects and the mild nature of my symptoms.
T108 11966-12071 Sentence denotes After that, the symptoms gradually improved and the weakness disappeared, although the numbness remained.
T109 12072-12116 Sentence denotes I was satisfied with the treatment protocol.
T110 12117-12132 Sentence denotes Learning points
T111 12133-12274 Sentence denotes Patients with Guillain-Barré syndrome (GBS) associated with SARS-CoV-2 infection may test negative for many known antiganglioside antibodies.
T112 12275-12429 Sentence denotes Careful diagnosis of GBS is required, because peripheral neuropathy in patients infected with SARS-CoV-2 may have causes other than autoimmune conditions.
T113 12430-12571 Sentence denotes Further studies and case reports are required to facilitate discussion of the mechanisms underlying GBS associated with SARS-CoV-2 infection.
T114 12573-12781 Sentence denotes Contributors: TH and OK performed and reviewed literature searches, interpreted and drafted the manuscript, and have both agreed to be personally accountable for the accuracy and integrity of the entire work.
T115 12782-12849 Sentence denotes TH performed examination and provided clinical care to the patient.
T116 12850-12882 Sentence denotes YH and KK analysed the antibody.
T117 12883-12965 Sentence denotes All authors reviewed and revised the manuscript and approved the final manuscript.
T118 12966-12974 Sentence denotes Funding:
T119 12975-13116 Sentence denotes The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
T120 13117-13137 Sentence denotes Competing interests:
T121 13138-13152 Sentence denotes None declared.
T122 13153-13185 Sentence denotes Patient consent for publication:
T123 13186-13195 Sentence denotes Obtained.
T124 13196-13223 Sentence denotes Provenance and peer review:
T125 13224-13267 Sentence denotes Not commissioned; externally peer reviewed.

LitCovid-PD-GlycoEpitope

Id Subject Object Predicate Lexical cue glyco_epitope_db_id
T1 1893-1901 GlycoEpitope denotes anti-GM1 http://www.glycoepitope.jp/epitopes/AN0713
T2 1898-1901 GlycoEpitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T3 1908-1912 GlycoEpitope denotes GQ1b http://www.glycoepitope.jp/epitopes/EP0069
T4 1917-1926 GlycoEpitope denotes anti-GD1b http://www.glycoepitope.jp/epitopes/AN0403
T5 1922-1926 GlycoEpitope denotes GD1b http://www.glycoepitope.jp/epitopes/EP0059
T6 4806-4809 GlycoEpitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T7 4816-4820 GlycoEpitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T8 4822-4826 GlycoEpitope denotes GD1b http://www.glycoepitope.jp/epitopes/EP0059
T9 4833-4844 GlycoEpitope denotes GalNAc-GD1a http://www.glycoepitope.jp/epitopes/EP0058
T10 4840-4844 GlycoEpitope denotes GD1a http://www.glycoepitope.jp/epitopes/EP0056
T11 4846-4850 GlycoEpitope denotes GT1a http://www.glycoepitope.jp/epitopes/EP0066
T12 4852-4856 GlycoEpitope denotes GT1b http://www.glycoepitope.jp/epitopes/EP0067
T13 4858-4862 GlycoEpitope denotes GQ1b http://www.glycoepitope.jp/epitopes/EP0069
T14 4879-4882 GlycoEpitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T15 9372-9380 GlycoEpitope denotes anti-GM1 http://www.glycoepitope.jp/epitopes/AN0713
T16 9377-9380 GlycoEpitope denotes GM1 http://www.glycoepitope.jp/epitopes/EP0050
T17 9387-9391 GlycoEpitope denotes GQ1b http://www.glycoepitope.jp/epitopes/EP0069
T18 9396-9405 GlycoEpitope denotes anti-GD1b http://www.glycoepitope.jp/epitopes/AN0403
T19 9401-9405 GlycoEpitope denotes GD1b http://www.glycoepitope.jp/epitopes/EP0059